Chromium Supplementation May Improve Memory in Older Adults
Results of a small pilot study, led by Robert Krikorian, PhD, UC associate professor of psychiatry, were presented this week to the medical community at an annual neurological meeting.
Chromium is a nutrient important to insulin signaling and has been shown to improve blood sugar control in patients with diabetes and insulin resistance. Picolinic acid (picolinate) is added to some chromium supplements to aid in absorption.
Insulin is a hormone that regulates how sugar (glucose) is stored and moved throughout the body and the brain. When glucose is not properly transported, the risk increases for a number of age-related disorders, including memory loss and dementia. Insulin resistancethe bodys inability to use insulin efficientlyhas been linked to physiological changes associated with Alzheimers disease.
Based on his knowledge of insulins role in brain function, Krikorian hypothesized that chromium supplementation might improve memory and brain function in older adults suffering from early memory decline.
Krikorian and his team conducted a double-blind, placebo-controlled trial of 21 older adults with early memory changes. Eleven study participants received 1,000 micrograms of chromium picolinate supplementation daily for 12 weeks. Ten study participants received a placebo.
The researchers assessed fine motor control and speed, and evaluated verbal memory by asking participants to learn and remember a list of words. Both assessments were performed prior to treatment and again during week 12.
Study results suggest that chromium picolinate supplementation enhanced memory and motor function, says Krikorian.
A subset of participants was also evaluated using functional magnetic resonance imaging (fMRI). The group was asked to perform a memory test during fMRI scans.
Scans of participants receiving chromium picolinate supplementation showed greater activation of the left frontal and left parietal cortices of the brain during the memory test, says Krikorian. We did not see the same level of increased activity in the placebo group.
Our findings suggest that chromium picolinate supplementation in older adults with early memory loss could enhance cognitive function, says Krikorian. We would need to further evaluate this treatment option in a larger study to truly assess the benefit and preventive potential.
Nutrition 21, a New-York based nutritional bioscience company, provided funding and supplements for Krikorians study.
Coauthors, all from UC, include Caleb Adler, MD, James Eliassen, PhD, and Marcelle Shidler, PhD.
Psychiatry faculty Jim Eliassen, PhD, (left) and Robert Krikorian
Tags
Related Stories
When grief doesn't end: Nursing PhD students bring a classroom theory to Ohio families
October 29, 2026
Most of us think of grief as something with an ending. A loss happens, it hurts, and over time the hurt fades. For many parents of children with developmental disabilities, it doesn't work that way. The sadness can quiet down for months or years and then come back. It might return on the first day of kindergarten, at a cousin's wedding, at a high school graduation, or on the day a young adult ages out of school services. Nurses and researchers have a name for this: chronic sorrow. Last October, two University of Cincinnati College of Nursing PhD students helped bring that name to a room of families, people with disabilities and the professionals who support them.
UC student's NFL internship leads to $20,000 gift to reduce loan burden
October 29, 2026
University of Cincinnati athletic training graduate student Savannah Posey interned with the Buffalo Bills during training camp and received a surprise $20,000 gift toward her student loans from safety C.J. Gardner-Johnson through his Ceedy Cares Foundation.
Who is using nicotine pouches?
October 28, 2026
A University of Cincinnati study found that nicotine pouch use increased sharply among U.S. adult tobacco users between 2021 and 2024. Using national YouGov survey data, researchers reported that “ever use” rose from 16.4% to 31.1%, while current use increased from 3% to 10.2%.